In part 2 of this commentary Patrick Bennett continues to discuss the convergence of LBA and LC–MS techniques including definitions of hybrid, selecting the appropriate technology and potential opportunities in hybrid LBA/LC–MS technology.
Browsing: Hybrid LBA/LC-MS
In part 1 of this commentary Patrick Bennett provides an overview of the adoption of LC–MS and LBA and their subsequent convergence in bioanalysis of large molecules.
In this editorial, featured in Bioanalysis 8(6), the changing landscape of protein and peptide drug development is discussed, with a focus on the hybrid LBA with LC-MS/MS.
Welcome to the Bioanalysis Zone Spotlight on Hybrid LBA/LC-MS! LBA is historically the gold standard…
Available to view on demand
This webinar presented a comprehensive view of hybrid LBA-LC/MS assays as they are currently being applied in the industry, and will describe the benefits they offer for the bioanalysis of proteins.
2015 White Paper on recent issues in bioanalysis: focus on new technologies and biomarkers (Part 2 – hybrid LBA/LCMS and input from regulatory agencies)
This White Paper (part 2 of 3) from the 2015 9th Workshop on Recent Issues in Bioanalysis (WRIB) covers the recommendations for hybrid LBA/LCMS and regulatory agencies’ inputs.
This White Paper focuses on the discussions, consensus and resulting recommendations on 16 recent issues (‘hot’ topics) in bioanalysis.